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Abstract
Transplantation from living or deceased donors has been limited by donor availability that is opposed to the increasing demand and by the risk of allograft loss 
rejection and immunosuppressive therapy toxicity. In recent years, xenotransplantation of metanephroi has offered a novel solution for the unlimited supply of human 
donor organs. However, even if in a most favourable and idyllic situation, in which the organ availability and its demand could be balanced using transplantation of 
animal embryonic organs, the future of this treatment would still be compromised without proper long-term storage procedure. Thus, based on the ongoing long-term 
storage necessities, this study was designed to investigate the effect of two specific time “window” of the metanephroi development (15 days-old and 16 days-old) on 
the in vivo developmental capacity and the developed morphologically normal glomeruli of vitrified metanephroi in non-immunosuppressive rabbits. Metanephroi 
originating from 15 and 16 days old rabbit embryos were vitrified using M22 solution and Cryotop® as a device. After three months of storage in liquid nitrogen, 
metanephroi were transplanted into non-immunosuppressed adult hosts by laparoscopy surgery. Twenty-one days after allotransplantation, 6 (32%) and 7 (35%) 
“new kidneys” were recovered. All the “new kidneys” recovered exhibited significant growth and mature glomeruli. However, histomorphometry analysis revealed that 
“new kidneys” developed from 16 days-old metanephroi exhibit a greater degree of maturity compared with 15 days-old metanephroi. Results obtained in the present 
study point out that, in rabbit model, vitrified 16 days-old metanephroi could be stored in liquid nitrogen, achieving good in vivo developmental capacity and and 
developing morphologically normal glomeruli after laparoscopy transplantation into non-immunosuppressed hosts.
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Introduction
In end-stage kidney disease, the kidneys no longer adequately 
clarify the blood of wastes and remove the excess fluids [1]. Then, 
organ transplantation provided the ideal method to restoring full 
physiological organ function [2]. However, transplantation from 
living or deceased donors has been limited by donor availability that is 
opposed to the increasing demand [2,3]. For this reason, patients with 
end-stage kidney disease are usually forced to receive dialysis treatment 
to support the lost kidney function. However, none of these treatments 
including peritoneal dialysis cure end-stage renal disease. It does not 
replace the kidneys’ role in metabolism regulation, endocrine function 
or homeostasis, includes blood pressure, electrolyte balance, acid-base 
balance, etc. [4-9]. Furthermore, dialysis is an expensive treatment, 
supposing a cost of 1518 million € in countries like Spain or 1.2 
billion in United Kingdom [10-12]. In other countries like Canada the 
estimated annual per-patient costs were $56,000 for peritoneal dialysis, 
$71,000 to $90,000 for home haemodialysis and $95,000 to $107,000 
for in-centre or satellite unit haemodialysis [13]. Furthermore, the 
dialysis centre capacity is limited and resources make impossible to 
provide more frequent or longer treatment sessions to patients [13-16]. 
In addition, the diet changes that patients must make, and the need 
to attend to receive dialysis treatment, affect negatively the life quality 
of patients and deplete its health [17]. For this, many patients define 
dialysis as more life to his years, but no more years to his life [18].
Paradoxically, for these reasons that evidence the superior benefits 
of kidney transplantation over dialysis and the growing incidence of 
end-stage renal disease have led to an exponential increase in the need 
for kidney transplantation worldwide [19]. In addition, it is known that 
five-year survival was considerably better after living-donor kidney 
transplantation (94%) or after cadaveric-kidney transplantation (76%) 
than on chronic dialysis (60%) [20]. These facts causes that the lack of 
these organs becomes in a very serious problem of global health and 
causes patients to be on long waiting lists to obtain a transplant. Only 
in USA, the length of waiting list has doubled over the past decade, 
reaching around 100.000 patients and a median waiting time of 4.5 
years [21]. In 2014, only 17.814 kidneys were transplanted, being 12.279 
from deceased donors and 5535 from living donors [22]. Thus, as long 
as the patient does not get an organ it will be dependent on dialysis, 
which have a higher risk for morbidity and mortality [19], dying 
nearly 5000 patients every year in this country [21]. In fact, the long‐
Garcia-Dominguez X (2017) Successful development of vitrified embryonic kidney after laparoscopy transplantation into non-immunosuppressed hosts
 Volume 10(3): 2-5Trends in Transplant, 2017         doi: 10.15761/TiT.1000228
term mortality risk was 68% lower in the case of the patient receives a 
transplant when compared with patients remaining on the waiting list 
[23]. However, it is not only a problem of USA. In European Union 
in late 2011, more than 42.000 patients were on waiting list and only 
18.712 transplants were performed, being a 20.6% from living donors 
[24]. Actually, in 2015 the situation isn’t better. Only 19,426 kidney 
transplants were performed, being a 68% from deceased donors, a 
31% from living donors and 1% from an unknown donor type [22]. So 
taking into account all this information, seeking alternative solutions 
to this grave problem is indispensable. 
In this point, regenerative medicine has garnered great attention 
in the last years because it has the potential to generate new organs 
for transplantation. Particularly, human kidney exhibits a remarkable 
complexity, coupled with the presence of at least 30 different 
specialized cells that have to be able to function together, for which 
their proper spatial distribution is indispensable [25]. Thus, the 
need for recapitulation the three-dimensionally integrated kidney 
structure is the reason because cell therapies with individual cells 
fail in restoring kidney function [26]. However, there is an open line 
of research that retakes the field of xeno-transplants as a possible 
solution to organ shortage. To date, rejection and zoonosis have 
limited the application of this kind of treatments [27,28]. However, 
transplantation of embryonic kidneys into non-immunosuppressed 
adult hosts can mature and growth as if they had not been extracted 
from the embryo. These embryonic kidneys or metanephroi are able 
to attract the formation of a vascular system from host (angiogenesis), 
undergoing maturation and exhibiting functional renal properties 
[26,29]. Dekel et al. [30] transplanted embryonic kidneys from both 
human and pig origins into mice, demonstrating that metanephroi 
were differentiated into functional nephrons evidenced by the dilute 
urine that they produce. However, it’s known that new renal tissue 
developed from metanephroi not only provide an excretion function 
but also an endocrine function, synthesising renal hormones such as 
renin and erythropoietin [31,32]. Furthermore, if metanephroi are 
transplanted beside bladders developed from cloacas, and if cloacal-
developed bladder was connected to the host ureters, new metanephro-
developed kidney produces and excretes urine through the recipient 
ureter, avoiding hydronephrosis and allowing the nascent kidney to 
continue their growth [33]. These findings, together with the scientific 
capability to produce specific pathogen-free animals [34] suggest than 
metanephroi transplantation could be a possible solution for kidney 
need [26,35].
Our group has been working on the development of a novel 
technique that allows the metanephroi transplantation procedure 
thought a minimal invasive procedure, presenting recently an effective 
way by laparoscopy [24,36-42]. To our best knowledge, all the previous 
studies were performed through open surgery, a fact that has limited the 
experiments on larger animals and should be avoided aimed at clinical 
application. However, even if in a most favourable and idyllic situation, 
in which the organ availability and its demand could be balanced 
using embryonic xeno-transplants, the future of this treatment would 
still be compromised without proper cryopreservation procedures 
[36,37]. Effective cryopreservation can permit long-term storage of the 
transplantable organ, dissociating the recuperation and transplantation 
time, allowing an adequate inventory control and quality assurance 
thought the pertinent laboratory analysis whose requires time to organ 
examination. To date, only small structures such as small ovaries, heart 
valves or corneas are the only macroscopic structures that retain the 
capacity to recover, at least in part, after vitrification [38]. A historical 
case was reported by Fahy et al., [38], who describe how one whole rabbit 
kidney survive and supported indefinitely the life of a recipient animal 
after vitrification procedure using M22 vitrification medium. Based 
on this knowledge, we recently described a method to cryopreserve 
metanephroi effectively using VM3 vitrification solution and Cryotop® 
as device [36,37]. Previously to our works, only Bottomley et al., [39] 
examined the cryopreservation of metanephroi, but only under in 
vitro conditions. In an effort to advance in organ cryopreservation, 
this study investigate the effect of two specific time “window” of the 
metanephroi development (15 days-old and 16 days-old) on the in vivo 
developmental capacity and the developed morphologically normal 
glomeruli of vitrified metanephroi in non-immunosuppressive rabbits.
Material and methods
All chemicals, unless otherwise stated, were reagent- grade and 
purchased from Sigma-Aldrich Química S.A. (Alcobendas, Madrid, 
Spain). All the experimental procedures used in this study were 
performed in accordance with Directive 2010/63/EU EEC for animal 
experiments and reviewed and approved by the Ethical Committee 
for Experimentation with Animals of the Polytechnic University of 
Valencia, Spain (research code: 2015/VSC/PEA/00170).
Animals 
New Zealand white females, 5 months old, were used as embryo 
donors and metanephroi recipients. The animals used came from 
the experimental farm of the Universidad Politécnica de Valencia. 
The rabbits were kept in conventional housing (with light alternating 
cycle of 16 light hours and eight dark hours, and under controlled 
environmental conditions: average daily minimum and maximum 
temperature of 17.5 and 25.5°C, respectively). All rabbits had free 
access to fresh food and water. 
Metanephroi recovery and vitrification
Metanephroi were surgically dissected from a 15 and 16-day-
old rabbit embryo under a dissecting microscope using previously 
described techniques [24,36-37,40-42] and vitrified within 1 h following 
the minimum essential volume method using Cryotop [40] as device 
and M22 [38] as vitrification solution. 
Metanephroi were first exposed for 3 min to 2.5 ml equilibration 
solution containing 1.68% w/v ethylene glycol (EG), 1.28% w/v 
formamide, 2.23% w/v dimethyl sulphoxide (DMSO), 0.3% w/v 
N-methylformamide (NMF), 0.4% w/v 3-methoxy-1,2-propanediol 
(MP), 0.28% w/v PVP K12 (polyvinylpyrrolidone of Mr 5000Da) and 
0.1% and 0.2% w/v final concentrations respectively of commercially 
available SuperCool X-1000 and SuperCool Z-1000 (ice blockers) 
in base medium (BM: DPBS + 20% foetal bovine serum, FBS) for 3 
min. Then, the metanephros were submerged into 2.5 ml of solution 
containing 4,82% w/v EG, 3.68% w/v formamide, 6.38% w/v DMSO, 
0.86% w/v NMF, 1.14% w/v MP, 0.8% w/v PVP K12 and 0.29% w/v 
with 0.57% w/v final concentrations respectively of SuperCool X-1000 
and SuperCool Z-1000 ice blockers in BM for 1 min. 
Finally, metanephroi were submerged into 2.5 ml of vitrification 
solution consisting of 16.84% w/v EG, 12.86% w/v formamide, 22.31% 
w/v DMSO, 3% w/v NMF, 4% w/v MP, 2.8% w/v PVP K12 and 1% w/v 
with 2% w/v final concentrations respectively of SuperCool X-1000 and 
SuperCool Z-1000 ice blockers in BM before being loaded into Cryotop 
devices and directly plunged into liquid nitrogen within 1 min. All 
manipulations were performed at room temperature (25 ± 1°C) and all 
the media were used at room temperature, except for the first warming 
solution, which was used at 37.5°C.
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Metanephros transplantation surgery
After 3 months of storage in liquid nitrogen, metanephroi were 
warmed and transplanted into recipients. For warming, metanephroi 
were submerged into 2.5 ml of a solution containing 1.25 M sucrose 
in BM for 1 min and later transferred stepwise into decreasing sucrose 
solutions (0.6, 0.3 and 0.15 M sucrose in BM) for 30 s before and then 
washed twice in BM for 5 min. Then, metanephroi were transplanted 
within 45 min after warming or collected (fresh). 
Host females were sedated by intramuscular injection of xylazine 
(5 mg/kg) (Rompun, Bayer AG, Leverkusen, Germany) and morphine 
chloride (3 mg/kg) (Morfina, B. Braun, Barcelona, Spain). As surgical 
preparation, anaesthesia was performed by intravenous injection of 
ketamine hydrochloride (35 mg/kg) (Imalgene®, Merial, S.A., Lyon, 
France) into the marginal ear vein. Firstly, animals were placed on an 
operating table in a vertical position (head down at 45-degree angle). 
Only one endoscope trocar was inserted into the abdominal cavity. 
Then, an epidural 17G needle (for 15-days-old metanephroi) or 
Cistofix® needle (for 16-days-old metanephroi) was inserted into the 
inguinal region. After identify a renal vessel in the retroperitoneal fat, 
a hole was performed adjacent to the vessel. Then, kidney precursor 
was aspirated in appropriate catheter using previously described 
techniques [24,36,37,41,42], and the catheter was introduced through 
the corresponding needle and insert into the performed hole. Between 
3 to 4 kidney precursors were transplanted in each host without 
immunosuppression (one metanephros per hole). After surgery, 
analgesia was administered for 3 days (0.03 mg/kg of buprenorphine 
hydrochloride, Buprex®, Esteve, Barcelona, Spain, each 12 hours, and 0.2 
mg/kg of meloxicam, Metacam®, 5 mg/mL; Norvet; Barcelona, Spain, 
every 24 hours). Also, all the recipients were treated with antibiotics 
(4 mg/kg of gentamicine (10% Ganadexil, Invesa, Barcelona, Spain) 
every 24-h for 3 days). No immunosuppression was given to recipients. 
Metanephroi transplantation was assessed in three sessions. 
Growth of metanephroi and histomorphometry of the renal 
corpuscle
The animals receiving implants were euthanatized at 3 weeks 
after transplantation. New kidneys were then removed, fixed in 4% 
paraformaldehyde solution and embedded in paraffin wax. New kidneys 
were cut into 5-μm histological sections and stained with haematoxylin 
and eosin. Kidneys from a 5-weeks (approximately 36 days) old rabbit 
were used as controls. The stained sections were examined with light 
microscopy for histological and histomorphometric analysis according 
with previous works [36,37]. In the histomorphometric measurements, 
20 renal corpuscle and glomeruli on each sample were measured (area 
and perimeter) in each of the groups – control and experimental. 
Photomicrographs were taken at total magnification of x1000. In 
addition, the glomerular tuft cellularity was estimated by counting the 
total number of nuclei of each glomerulus. Photomicrographs were 
measured using ImageJ analysis software (free software http://rsb.info.
nih.gov/ij/). Kidneys originating from a 5-week-old rabbit (coeval with 
the metanephroi age) were used as controls. 
Statistical analysis
The renal corpuscle and glomeruli measured (area and perimeter), 
and the glomerular tuft cellularity were compared by analysis of 
variance ANOVA with sample type (fresh and vitrified) as a fixed factor 
and replicate as random factor. The replicate was non-significant and 
was removed from the model. Differences of p<0.05 were considered 
significant. Data are shown as means ± standard error means (S.E.M.). 
All analyses, except mixed model (SAS Institute Inc., Cary, NC, USA) 
were performed with SPSS 21.0 software package (SPSS Inc., Chicago, 
Illinois, USA, 2002) (Table 1).
Results
Six rabbit females were used as embryo donors. Three of the females 
were euthanatized 15 days since artificial insemination (to obtained 
15-days-old metanephroi) and the rest were euthanatized after 16 days 
since artificial insemination (obtaining16-days-old metanephroi). In 
total, 35 metanephroi from 15-days-old embryos and 42 from 16-days-
old embryos were carefully micro-dissected. After this, 19 vitrified 
and 16 fresh metanephroi from 15-days-old embryos and 22 vitrified 
and 20 fresh metanephroi from 16-days-old were transplanted into 
20 host. Twenty-one days after transplantation procedure, the “new 
kidneys” were recovered and analysed (Figure 1). In total, 6 (32%) 
vitrified and 7 (44%) fresh metanephroi from 15-days-old embryos 
and 7 (35%) vitrified and 12 (55%) fresh metanephroi from 16-days-
old were successfully grown. All the new kidneys, developed from both 
ages (15 and 16 days) independently of the experimental group (fresh 
or vitrified), underwent differentiation and developed histological 
mature glomeruli (Figure 1). Histomorphometry analysis showed 
similar values between vitrified and fresh metanephroi from 16-days-
old, and between fresh metanephroi from 15-days-old embryos and 
control samples. All the parameters of “new kidneys” from vitrified 
and fresh metanephroi from 16-days-old were statistically higher than 
vitrified and fresh metanephroi from 15-days-old (p < 0.05). Similar 
glomerular tuft cellularity was observed between “new kidneys” from 
vitrified metanephroi for both ages. In addition, in all the new kidneys 
parameters were significantly higher than in control group.
Discussion
To our best acknowledge, this is the first study that evaluated the 
effect of the metanephroi age on the in vivo developmental capacity 
and the developed morphologically normal glomeruli after long-term 
storage period. After transplant, both metanephroi ages (15 and 16 
days old) underwent differentiation and growth, became vascularised 
by host blood vessels, and developed histological and morphologically 
mature glomeruli. Previously to our recent studies [24,36,37,41] only 
one study had evaluated the metanephroi cryoconservation [39], 
but the difference in methodology (in vitro vs. in vivo) to test the 
Metanephroi age Group n
Renal corpuscle Glomerulus
Area (μm2) Perimeter (μm) Area (μm2) Perimeter (μm) Cells number
Control 4 2778 ± 199.8c 188.5 ± 5.53c 2221 ± 152.1c 169.1 ± 4.96c 54 ± 2a
15 days
Fresh 7 3222 ± 200.8c 200.5 ± 5.53c 2267 ± 154.3c 167.9 ± 4.96c 42 ± 2c
Vitrified 6 3834 ± 214.2b 223.1 ± 5.93b 2726 ± 162.9b 189.3 ± 5.32b 50 ± 2a,b
16 days
Fresh 12 6164 ± 233.8a 283.4 ± 6.34a 4498 ± 176.7a 242.4 ± 5.69a 47 ± 2b
Vitrified 7 5716 ± 229.2a 271.3 ± 6.30a 4045 ± 174.3a 231.5 ± 5.66a 52 ± 2a
n: Number of new kidneys or control kidneys. Data are expressed as mean ± SD. a,b,c: Data in the same column with uncommon letters are different (p < 0.05). 
Table 1. Histomorphometric quantification of renal corpuscle of kidneys developed after allotransplantation of vitrified and fresh metanephroi.
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metanephroi viability after its vitrification difficult the comparison 
between the studies. However, vitrification was presented as the more 
promising technique. The results of the present work are consistent 
with our previous experiments [24,36-37,41].
Cryobiology is the science that studies the effects of low 
temperatures on living organism and its aim is to achieve cells become 
immortals at low temperatures though stopping its metabolism. One 
of the major problems to obtain this goal is the need to avoid the ice 
crystal formation [43,44] that causes cell death. Presumably, the cause 
for our improvement was due to the vitrification technique, in which 
the liquids in a living system are turned into the glassy state without 
ice crystal formation [41]. In this study, we evaluate the vitrification 
solution named M22, which had already demonstrated its effectiveness 
in the preservation of renal tissue [38]. In addition, we combined this 
solution with Cryotop® device [40], which minimise the volume to be 
vitrified, facilitating the rapid transfer of heat to liquid nitrogen [36,37] 
that allows the vitrification procedure. Marco-Jimenez, et al. [36] and 
Garcia-Dominguez et al. [37] had already observed that the small size 
of metanephroi could allow an adequate diffusion and equilibration of 
cryoprotectants within the organ cells and the vitrification medium, 
a fact that could explain also the effectiveness in the vitrification 
procedure. This is in concordance with the fact that to date, only small 
biological structures had been vitrified and recovered later. Another 
point in favour of the metanephroi survival after it be thawed is that 
this embryonic organ is avascular and attract blood vasculature directly 
from the host not requiring immediate anastomosis as in the case of 
mature vascularized adult organs [41,42].
We previously demonstrated that the time window in which rabbit 
metanephroi can implant and develop into new kidneys are 15 and 
16 days [24,36,37]. In our previous metanephroi vitrification studies, 
based on VM3 vitrification solution, metanephroi from 15 days-old 
embryos exhibit better growth rate than metanephroi from 16 days-old 
embryos. The result could be explained due to 16 days-old metanephroi 
larger size. However, in the present study, no differences were observed 
between both metanephroi ages. A plausible explanation could be that 
M22 vitrification medium includes components that might help in the 
diffusion of cryoprotective agents into the whole metanephroi structure. 
However, this study demonstrated a clear effect of metanephroi age on 
the renal histomorphometry. Specifically, developed new kidneys from 
16 days-old vitrified metanephroi exhibited similar renal glomerular 
histomorphometry than fresh metanephroi. Furthermore, glomerulus 
cell density was maintained in from 16 days-old vitrified metanephroi 
compared with control. In contrat, vitrification of 15 days-old 
metanephroi disrupts histomorphometric parameters compared with 
fresh metanephroi. Nevertheless, our results indicates that vitrification 
procedure neither affect negatively the development capacity of 
15 days-old metanephroi. In general, all the histomorphometric 
parameters relating to new kidneys are higher than control samples. In 
part, these results could be explained by the fact that these new renal 
structures were not connected to the host’s urinary system. Under 
this condition, unconnected metanephroi become hydronephrotic, 
accumulating the liquid inside the new kidney dilating the glomerular 
structures [36,37,41,42]. In this paper we demonstrated than 
metanephroi vitrification using M22 medium as vitrification solution 
support the developmental capability of both 15 days-old and 16 
days-old metanephroi. However, although we have focused the study 
solely from the point of the cryobiological effect, it is important to 
say that some authors have already shown that transplants of fresh 
kidney precursors are able to filter blood producing urine [33,35] and 
synthetizing renal hormones [31,32] such as renin and erythropoietin. 
In the future, it would be interesting demonstrate the same capacities 
in developed kidneys from vitrified metanephroi. This study, together 
with our previous results [24,36,37,41,42], reinforce the idea that it 
is possible to create a biobank of renal precursors, a fact that would 
facilitate inventory control and give the necessary time to guarantee the 
safety of the transplant. 
In conclusion, the present study shows that storing vitrified 16 
days-old metanephroi in liquid nitrogen is an effective long-term 
storage option that maintains metanephroi developmental viability 
and could achieve good developmental capacity, and developing 
morphologically normal glomeruli after laparoscopy transplantation 
into non-immunosuppressed hosts. Further studies are needed in order 
to support our results and understand the potential future implication 
of this technique in the clinical practice.
Figure 1. Metanephroi Development. (A) New-kidney developed from metanephroi. Representative photomicrograph of the renal corpuscles (400x): G; Glomerulus. RC; Renal Corpuscle. 
BS; Bowman’s space. (B) Renal corpuscle of the control kidney originating from 5-week-old rabbit (coeval with metanephros age). (C) Renal corpuscle of a fresh 15 days kidney precursor 
3 weeks after transplantation. (D) Renal corpuscle of vitrified 15 days kidney precursor 3 weeks after transplantation. (E) Renal corpuscle of a fresh 16 days kidney precursor 3 weeks after 
transplantation. (F) Renal corpuscle of vitrified 16 days kidney precursor 3 weeks after transplantation.
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